Alexey Ushmorov

7PUBLICATIONS
17CO-AUTHORS
Haematological tumoursMolecular targetsMedical molecular engineering of nucleic acids and proteinsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 20, 2026
mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia.

|Jan 28, 2026
Intracellular Oxidant Levels Are Crucial for Cell Survival and JAK/STAT Signaling in Classical Hodgkin's Lymphoma.

Julia Wildfeuer, Rashmi P Dheenadayalan, Svenja Hartung

|Jul 10, 2025
Beyond FOXO1: AS1842856 inhibits GSK3 to enhance cytotoxic effects in B-ALL.

Franz Ketzer, Ulrike Büttner, Daniel Geist

|Nov 25, 2023
Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1-KMT2A Interaction.

Tatjana Magdalena Wolffhardt, Franz Ketzer, Stefano Telese

|Jan 11, 2022
CCND3 is indispensable for the maintenance of B-cell acute lymphoblastic leukemia.

Franz Ketzer, Hend Abdelrasoul, Mona Vogel

|Nov 14, 2019
Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma.

Franziska Gehringer, Stephanie Ellen Weissinger, Peter Möller

Pageof 2

Frequent Collaborators

3 joint publications

Franz Ketzer

2 joint publications

Thomas Wirth

1 joint publications

Lotteke Jym Swier

1 joint publications

Markus Müschen